Last reviewed · How we verify
Monolayer group
At a glance
| Generic name | Monolayer group |
|---|---|
| Sponsor | LG Chem |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Minimal Offloading Dressing for the Treatment of Plantar Diabetes-related Foot Ulcers (NA)
- Comparison of Flexural Strength and Flexural Modulus of Conventional and Graphene-Reinforced Polymethyl Methacrylate (NA)
- Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix (NA)
- BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Monolayer group CI brief — competitive landscape report
- Monolayer group updates RSS · CI watch RSS
- LG Chem portfolio CI